Your browser doesn't support javascript.
loading
Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D.
Hoppe, Jordana E; Wagner, Brandie D; Kirk Harris, J; Rowe, Steven M; Heltshe, Sonya L; DeBoer, Emily M; Sagel, Scott D.
Afiliação
  • Hoppe JE; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Electronic address: jordana.hoppe@childrenscolorado.org.
  • Wagner BD; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Kirk Harris J; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Rowe SM; Department of Medicine, Pediatrics and Cell Developmental and Integrative Biology, University of Alabama Birmingham, Birmingham, AL, England.
  • Heltshe SL; Department of Pediatrics, University of Washington, Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle, WA, United States.
  • DeBoer EM; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Sagel SD; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
J Cyst Fibros ; 21(6): 950-958, 2022 11.
Article em En | MEDLINE | ID: mdl-35440409

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos para o Sistema Respiratório / Fibrose Cística / Aminofenóis Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos para o Sistema Respiratório / Fibrose Cística / Aminofenóis Idioma: En Ano de publicação: 2022 Tipo de documento: Article